Effect of Collavant® n2 in Healthy Male Adults With Exercise-induced Joint Discomfort.
In plain words A study of type II Collagen in male participants 40 to 65, run by Bioiberica. It plans to enroll about 80 people at 1 site, none in the US.
Who it lists and where
Who the trial lists, as registered
Lists male participants 40 to 65; healthy volunteers accepted. Conditions: Healthy Adult Male.
- Healthy physically active male adults (amateur runners) with exercise-induced joint discomfort, aged between 40 and 65 years
- Activity level: Amateur runners who train regularly a minimum of 150 minutes per week, divided into 2 or more sessions per week during at least 3 months. Principally, subjects training for popular running events of 10 Kms.
- Joint discomfort after activity: Self-reports target knee discomfort after training by a score of at least 20 mm VAS at screening. Discomfort persistent for at least 2w.
- Be willing to refrain from starting any new dietary supplements during the entire study that have any underlying joint benefits (collagen, glucosamine, chondroitin, MSM, Hyaluronic Acid, Turmeric, Natural Eggshell Membrane, Omega-3 fatty…
2 more inclusion criteria and the exclusion criteria are on the listing.
What it tests, as registered
Native type II collagen (Collavant® n2); Placebo
Registered summary
The present clinical study has been designed to evaluate the effect of Collavant® n2 at a daily dose of 40 mg on joint function and performance in healthy, amateur male runners with exercise-induced knee discomfort.
Where, as registered
No US site; Spain (1).